Eilmeldung
USStartup Battlefield 200 Applications Close June 8 for TechCrunch Disrupt 2026USSection 702 Reauthorization Deadline Looms Amid Controversy Over Intelligence AppointmentUSMaine Senate Candidate Graham Platner Faces Calls to Exit Race Amid Toxic Behavior AllegationsUSRansomware Gang Escalates Attacks with In-Person Data Theft from Law FirmsUSMinnesota GOP's Moment of Silence for Derek Chauvin Sparks OutrageUSAlbania Protests Over Planned Luxury Resort Linked to Ivanka and Jared KushnerUSBroadway Sees Record $1.91 Billion in Ticket Sales Amid Economic UncertaintyUSFDA Investigation into Infant Botulism Outbreak Falls Short of Identifying Root CauseUSReid Hoffman Steps Down from Microsoft Board to Focus on AI Startup ManusUSTech Layoffs Drive Workers to Unexpected Careers, Highlighting Shifts in Labor MarketUSStartup Battlefield 200 Applications Close June 8 for TechCrunch Disrupt 2026USSection 702 Reauthorization Deadline Looms Amid Controversy Over Intelligence AppointmentUSMaine Senate Candidate Graham Platner Faces Calls to Exit Race Amid Toxic Behavior AllegationsUSRansomware Gang Escalates Attacks with In-Person Data Theft from Law FirmsUSMinnesota GOP's Moment of Silence for Derek Chauvin Sparks OutrageUSAlbania Protests Over Planned Luxury Resort Linked to Ivanka and Jared KushnerUSBroadway Sees Record $1.91 Billion in Ticket Sales Amid Economic UncertaintyUSFDA Investigation into Infant Botulism Outbreak Falls Short of Identifying Root CauseUSReid Hoffman Steps Down from Microsoft Board to Focus on AI Startup ManusUSTech Layoffs Drive Workers to Unexpected Careers, Highlighting Shifts in Labor Market
Newsgather
Back|FDA Investigation into Infant Botulism Outbreak Falls Short of Identifying Root Cause
FDA Investigation into Infant Botulism Outbreak Falls Short of Identifying Root Cause
GesundheitAI
Ars Technica·18 sa önce·🇺🇸United States·Gesundheit

FDA Investigation into Infant Botulism Outbreak Falls Short of Identifying Root Cause

4 dk okuma·%70 önem·766 kelime
#botulismoutbreak#infantformula#ByHeart#FDAinvestigation#foodsafety
A
Ars Technica
Yayıncı
Schriftgröße

The Food and Drug Administration this week posted what critics call an “underwhelming” epilogue to the devastating outbreak of botulism in babies, which was linked to spore-contaminated formula made by ByHeart. Despite clear tracking of the contamination, the regulator still doesn’t know how the bacteria arrived in the formula—or how to prevent it from happening again. [...] ByHeart said it is working to resume infant formula production and is developing more sensitive testing for C. botulinum.

This article was originally published by Ars Technica.

Related Stories